Ashwagandha has become one of the most heavily marketed herbal supplements, particularly in the “adaptogen” and stress-relief categories. The word “adaptogen” itself is worth examining — it has no regulatory definition and appears on labels primarily as marketing language. The interesting thing about ashwagandha is that unlike many supplements that are pure marketing, there’s genuine research behind some of its claimed effects. The challenge is knowing where the evidence ends and the exaggeration begins.

What the evidence actually supports

Stress and cortisol reduction. This is where the ashwagandha evidence is strongest and most consistent. Multiple well-designed randomised controlled trials have found that ashwagandha supplementation at doses of 300–600mg of a standardised extract per day significantly reduces perceived stress scores and, in several studies, measurably reduces serum cortisol. The effect is real and meaningful for people under chronic stress, not a marginal or inconsistent finding. This is the most evidence-backed use of the supplement.

Sleep quality. Several studies show improvements in sleep onset latency and sleep quality with ashwagandha. This is plausible given the cortisol-reducing effects — lower cortisol in the evening supports better sleep architecture. Effect sizes are modest but consistent across multiple trials.

Physical performance. Some research shows modest improvements in muscular strength and recovery, VO2 max, and endurance in trained individuals. Effect sizes are small relative to training itself but real. This is the least robust of the three main evidence areas.

The extract quality gap — KSM-66 and Sensoril

Most of the positive ashwagandha research was conducted on specific standardised extracts — primarily KSM-66 (a root extract standardised to 5% withanolides, the active compounds) and Sensoril (a root and leaf extract standardised to 10% withanolides). The studies used these branded extracts at specific doses.

Generic ashwagandha powder or non-standardised extracts are not equivalent. They may contain significantly lower or variable amounts of the active withanolides. A product labelled “ashwagandha 500mg” without specifying KSM-66, Sensoril, or another standardised extract is not the product used in the research that supports the claims being made on its label. This is one of the clearest cases in the supplement industry of a distinction that marketing obliterates but formulation quality defines.

What’s exaggerated

Claims around thyroid support, testosterone restoration, and dramatic hormonal rebalancing are largely unsupported or based on very limited evidence. A few studies show modest effects in these areas; many marketing materials treat them as established. Dramatic transformation claims — “eliminates stress,” “resets your hormones” — are unsupported regardless of the extract quality.

Safety and duration

Ashwagandha has a good safety profile for most people at typical doses over periods studied in research (typically 8–12 weeks). Rare case reports of liver injury have been associated with ashwagandha use, warranting caution with very high doses or long-term continuous supplementation without breaks. Most practitioners suggest cycling use — taking it for 8–12 weeks and pausing — though this is precautionary rather than strongly evidence-mandated. Avoid during pregnancy.